Results 181 to 190 of about 17,036,332 (312)

Pareceristas do volume 11

Caderno Brasileiro de Ensino de Física, 1994
Sônia Silveira Peduzzi
doaj  

Editorial - Volume 11, Number 1

West African Journal of Open and Flexible Learning, 2022
Christine Ofulue
doaj  

Corrigendum to "Nanoparticles of natural product-derived medicines: Beyond the pandemic" [Heliyon Volume 11, Issue 4, February 28, 2025, Article e42739]. [PDF]

Heliyon
Herdiana Y.
europepmc   +1 more source

Cell surface CD11c as a neutrophil aging marker molecule

FEBS Open Bio, EarlyView.
Cell surface CD11chi neutrophils were more aged and had better phagocytic function than CD11c−/lo neutrophils. Transcriptomic analysis of CD11chi neutrophils and CD11c−/lo neutrophils in pediatric population showed that the most difference was seen in infants.
Sophia Koutsogiannaki, Fahd Alhamdan, Erik Malm, Marie Bermudez, Samuel Y. Kim, Koichi Yuki   +5 more
wiley   +1 more source

Index to volume 11 [PDF]

Oral Surgery, Oral Medicine, Oral Pathology, 1958
openaire   +2 more sources

Selected publications regarding lower extremity chronic ischemia and the diabetic foot from the <i>Journal of Vascular Surgery</i>: Cases and Innovative Reports 2025, Volume 11. [PDF]

J Vasc Surg Cases Innov Tech
Chung J.
europepmc   +1 more source

Genetic dissection of human ABCE1 in yeast reveals separable requirements for ribosome recycling and suppression of aberrant reinitiation

FEBS Open Bio, EarlyView.
Human ABCE1 cannot functionally replace its yeast ortholog. Yeast–human chimera analysis identified NBD1 as a major interspecies barrier. Genetic screening yielded hABCE1 revertants that rescue yeast viability but fail to suppress aberrant translation reinitiation in the 3′ UTR.
Eriko Nakata, Yuxin Li, Kei Endo, Koichi Ito   +3 more
wiley   +1 more source

Corrigendum to "Development and evaluation of clotrimazole microemulsions for topical application: Effects of HLB value of surfactant mixture and cosurfactant type on formulation design" [International Journal of Pharmaceutics: X Volume 11, (June 2026), 100469]. [PDF]

Int J Pharm X
Fang CW, Lin YW, Chiu IH, Wu PC.
europepmc   +1 more source

IGF2 knockout reduces but does not abolish osteosarcoma growth in vitro and in vivo

FEBS Open Bio, EarlyView.
To test whether endogenous IGF2 promotes osteosarcoma growth, IGF2 was knocked out in Saos2 cells via CRISPR‐Cas9. KO cells showed reduced proliferation in vitro, and knockout xenografts in mice reached only ~25% of wild‐type tumor volume. Insulin‐like growth factor 2 (IGF2) is implicated in osteosarcoma, but direct functional evidence of its role is ...
Shun Yao, Marco Archetti
wiley   +1 more source

Scottish Studies, Volume 11 (1967): Full Volume

Scottish Studies, 1967
[Editor]
doaj